Survival of patients with glioblastoma multiforme treated by intraoperative high‐activity cobalt 60 endocurietherapy

P. P. Kumar, R. R. Good, E. O. Jones, A. A. Patil, L. G. Leibrock, Rodney D McComb

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

The authors report their initial treatment results in 49 patients with glioblastoma multiforme (GM) who received intraoperative endocurietherapy (ECT) with high‐activity cobalt 60 (60Co) probe. Thirty poor prognosis (unresectable tumor) patients (Group I) with newly diagnosed GM were treated by either biopsy or subtotal excision, followed by 20.00‐Gy single‐fraction 60Co probe ECT, and 60.00‐Gy external‐beam radiation therapy (EXRT) (80.00 Gy total tumor dose). Nineteen patients (Group II) with recurrent, previously resected and externally irradiated GM were retreated with 20.00‐Gy single‐fraction 60Co probe ECT alone. The authors' initial experience with intraoperative ECT of GM is discussed.

Original languageEnglish (US)
Pages (from-to)1409-1413
Number of pages5
JournalCancer
Volume64
Issue number7
DOIs
StatePublished - Oct 1 1989

Fingerprint

Glioblastoma
Cobalt
Survival
Neoplasms
Radiotherapy
Biopsy
Therapeutics

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Survival of patients with glioblastoma multiforme treated by intraoperative high‐activity cobalt 60 endocurietherapy. / Kumar, P. P.; Good, R. R.; Jones, E. O.; Patil, A. A.; Leibrock, L. G.; McComb, Rodney D.

In: Cancer, Vol. 64, No. 7, 01.10.1989, p. 1409-1413.

Research output: Contribution to journalArticle

Kumar, P. P. ; Good, R. R. ; Jones, E. O. ; Patil, A. A. ; Leibrock, L. G. ; McComb, Rodney D. / Survival of patients with glioblastoma multiforme treated by intraoperative high‐activity cobalt 60 endocurietherapy. In: Cancer. 1989 ; Vol. 64, No. 7. pp. 1409-1413.
@article{ece506315dfc40838cd89f16eca61f9c,
title = "Survival of patients with glioblastoma multiforme treated by intraoperative high‐activity cobalt 60 endocurietherapy",
abstract = "The authors report their initial treatment results in 49 patients with glioblastoma multiforme (GM) who received intraoperative endocurietherapy (ECT) with high‐activity cobalt 60 (60Co) probe. Thirty poor prognosis (unresectable tumor) patients (Group I) with newly diagnosed GM were treated by either biopsy or subtotal excision, followed by 20.00‐Gy single‐fraction 60Co probe ECT, and 60.00‐Gy external‐beam radiation therapy (EXRT) (80.00 Gy total tumor dose). Nineteen patients (Group II) with recurrent, previously resected and externally irradiated GM were retreated with 20.00‐Gy single‐fraction 60Co probe ECT alone. The authors' initial experience with intraoperative ECT of GM is discussed.",
author = "Kumar, {P. P.} and Good, {R. R.} and Jones, {E. O.} and Patil, {A. A.} and Leibrock, {L. G.} and McComb, {Rodney D}",
year = "1989",
month = "10",
day = "1",
doi = "10.1002/1097-0142(19891001)64:7<1409::AID-CNCR2820640707>3.0.CO;2-R",
language = "English (US)",
volume = "64",
pages = "1409--1413",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "7",

}

TY - JOUR

T1 - Survival of patients with glioblastoma multiforme treated by intraoperative high‐activity cobalt 60 endocurietherapy

AU - Kumar, P. P.

AU - Good, R. R.

AU - Jones, E. O.

AU - Patil, A. A.

AU - Leibrock, L. G.

AU - McComb, Rodney D

PY - 1989/10/1

Y1 - 1989/10/1

N2 - The authors report their initial treatment results in 49 patients with glioblastoma multiforme (GM) who received intraoperative endocurietherapy (ECT) with high‐activity cobalt 60 (60Co) probe. Thirty poor prognosis (unresectable tumor) patients (Group I) with newly diagnosed GM were treated by either biopsy or subtotal excision, followed by 20.00‐Gy single‐fraction 60Co probe ECT, and 60.00‐Gy external‐beam radiation therapy (EXRT) (80.00 Gy total tumor dose). Nineteen patients (Group II) with recurrent, previously resected and externally irradiated GM were retreated with 20.00‐Gy single‐fraction 60Co probe ECT alone. The authors' initial experience with intraoperative ECT of GM is discussed.

AB - The authors report their initial treatment results in 49 patients with glioblastoma multiforme (GM) who received intraoperative endocurietherapy (ECT) with high‐activity cobalt 60 (60Co) probe. Thirty poor prognosis (unresectable tumor) patients (Group I) with newly diagnosed GM were treated by either biopsy or subtotal excision, followed by 20.00‐Gy single‐fraction 60Co probe ECT, and 60.00‐Gy external‐beam radiation therapy (EXRT) (80.00 Gy total tumor dose). Nineteen patients (Group II) with recurrent, previously resected and externally irradiated GM were retreated with 20.00‐Gy single‐fraction 60Co probe ECT alone. The authors' initial experience with intraoperative ECT of GM is discussed.

UR - http://www.scopus.com/inward/record.url?scp=0024434366&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024434366&partnerID=8YFLogxK

U2 - 10.1002/1097-0142(19891001)64:7<1409::AID-CNCR2820640707>3.0.CO;2-R

DO - 10.1002/1097-0142(19891001)64:7<1409::AID-CNCR2820640707>3.0.CO;2-R

M3 - Article

C2 - 2550121

AN - SCOPUS:0024434366

VL - 64

SP - 1409

EP - 1413

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 7

ER -